SCCA, Fred Hutchinson Cancer Research Center, and UW Medicine form the only NCI-designated comprehensive cancer centers in the Northwest. This group of organizations receives more funding for cancer research than any other NCI site in the country.
In 2010, over 300 oncologists, surgeons, radiologists, pathologists, and research physicians treated over 5,302 patients for many types of cancers including leukemia, lymphoma, breast, prostate, lung, and colon cancer. SCCA patients have access to the latest cancer treatments including stem cell and bone marrow transplantation, gene therapy, specialized antibody therapies, high-dose chemotherapy, radiation therapy, immunotherapy, minimally invasive surgical techniques, and other specialized therapies. SCCA patients may be seen at the SCCA outpatient clinic on Lake Union or at UW Medical Center.Pediatric patients may be seen at the SCCA outpatient clinic and Seattle Children’s. If overnight hospital stays are necessary, adult patients go to UWMC and pediatric patients go to Seattle Children’s.
The Fred Hutchinson Bone Marrow Transplant Program at SCCA performed nearly 450 bone marrow transplants in 2008, and was ranked first in outcomes in a five-year study by the National Bone Marrow Donor Program that measured one-year survival rates of patients among 122 transplant centers in the United States.
SCCA Purpose and Mission
Seattle Cancer Care Alliance (SCCA) unites doctors from Fred Hutchinson Cancer Research Center, UW Medicine, and Seattle Children’s in one world-class treatment center. SCCA was incorporated in 1998 as a separate, jointly governed non-profit that includes the cancer programs of the three partners. Each partner has equal ownership of SCCA. Dr. Fred Appelbaum is the Executive Director of SCCA. SCCA’s purpose is to provide state-of-the-art, patient and family centered care; support the conduct of cancer clinical research and education; enhance access to improved cancer interventions; and advance the standard of cancer care regionally and beyond.